Recently, a study showed that siRNA-mediated silencing of LAMB3 could enhance the sensitivity of head and neck squamous cell carcinoma cells to cisplatin (49), which may explain why PIGR can also increase the sensitivity of CRC cells to cisplatin. This evidence concerns the gene LAMB3 and colorectal carcinoma.